Can a new dissolvable dressing stop surgical bleeding faster?

NCT ID NCT07764055

Completed Disease control Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial is testing whether a new absorbable dressing made from oxidized cellulose can safely and effectively stop bleeding during surgery. The study will compare it to a standard hemostatic dressing in about 288 adults undergoing various surgical procedures. The main goal is to see if the new dressing stops bleeding within 5 minutes of application. Participants will be monitored for up to 6 months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Absorbable multilayer fibrillar regenerated oxidized cellulose dressing
What this could lead to: If successful, this could offer surgeons a new, effective option to control bleeding during operations, potentially improving safety and outcomes.
What could go wrong: This is a non-inferiority trial, so the new dressing may only be as good as, not better than, the existing one. Results are preliminary until the full trial is analyzed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMORRHAGE OXIDIZED REGENERATED CELLULOSE SURGICAL BLEEDING

Contacts and locations

Locations

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

Hangzhou, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, China
The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, China
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai, China
Zhejiang Provincial People's Hospital

Hangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.